Did Rem miss the primary end point The primary
Post# of 148158
The primary endpoint evaluated patients at Day 11 on a 7-point ordinal scale
and the result at Day11
the improvement in clinical status at Day 11 was not statistically different compared with the standard of care group (OR, 1.31; 95% confidence interval, 0.88-1.95; p=0.183).
However, their Day5 p value is 0.017 . No way they can be better than Leron.
found patients randomized to a 5-day course of Veklury plus standard of care were 65 percent more likely to have an improvement in clinical status compared with those randomized to standard of care alone (OR, 1.65; 95% confidence interval, 1.09-2.48; p=0.017).
Any Dr here can check out how valid is their p-value?